98 related articles for article (PubMed ID: 25056130)
21. A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties.
Chaubey B; Tripathi S; Ganguly S; Harris D; Casale RA; Pandey VN
Virology; 2005 Jan; 331(2):418-28. PubMed ID: 15629784
[TBL] [Abstract][Full Text] [Related]
22. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence polarization for the evaluation of small-molecule inhibitors of PCAF BRD/Tat-AcK50 association.
Hu P; Wang X; Zhang B; Zhang S; Wang Q; Wang Z
ChemMedChem; 2014 May; 9(5):928-31. PubMed ID: 24474698
[TBL] [Abstract][Full Text] [Related]
24. The Chinese herb-derived Sparstolonin B suppresses HIV-1 transcription.
Deng X; Zhang Y; Jiang F; Chen R; Peng P; Wen B; Liang J
Virol J; 2015 Jul; 12():108. PubMed ID: 26206295
[TBL] [Abstract][Full Text] [Related]
25. Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors.
Pang R; Zhang C; Yuan D; Yang M
Bioorg Med Chem; 2008 Sep; 16(17):8178-86. PubMed ID: 18693018
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion.
Nagashima KA; Thompson DA; Rosenfield SI; Maddon PJ; Dragic T; Olson WC
J Infect Dis; 2001 Apr; 183(7):1121-5. PubMed ID: 11237840
[TBL] [Abstract][Full Text] [Related]
28. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
30. Olean-18-ene triterpenoids from Celastraceae species inhibit HIV replication targeting NF-kB and Sp1 dependent transcription.
Osorio AA; Muñóz A; Torres-Romero D; Bedoya LM; Perestelo NR; Jiménez IA; Alcamí J; Bazzocchi IL
Eur J Med Chem; 2012 Jun; 52():295-303. PubMed ID: 22487595
[TBL] [Abstract][Full Text] [Related]
31. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process.
Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A
Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615
[TBL] [Abstract][Full Text] [Related]
32. 4-Phenylcoumarins as HIV transcription inhibitors.
Bedoya LM; Beltrán M; Sancho R; Olmedo DA; Sánchez-Palomino S; del Olmo E; López-Pérez JL; Muñoz E; San Feliciano A; Alcamí J
Bioorg Med Chem Lett; 2005 Oct; 15(20):4447-50. PubMed ID: 16137881
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
34. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication.
Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O
J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026
[TBL] [Abstract][Full Text] [Related]
35. Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection.
Tamamura H; Imai M; Ishihara T; Masuda M; Funakoshi H; Oyake H; Murakami T; Arakaki R; Nakashima H; Otaka A; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
Bioorg Med Chem; 1998 Jul; 6(7):1033-41. PubMed ID: 9730240
[TBL] [Abstract][Full Text] [Related]
36. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
Lavigne C; Yelle J; Sauve G; Thierry AR
AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
[TBL] [Abstract][Full Text] [Related]
37. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.
Nardese V; Longhi R; Polo S; Sironi F; Arcelloni C; Paroni R; DeSantis C; Sarmientos P; Rizzi M; Bolognesi M; Pavone V; Lusso P
Nat Struct Biol; 2001 Jul; 8(7):611-5. PubMed ID: 11427892
[TBL] [Abstract][Full Text] [Related]
38. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes.
Zheng YT; Ben KL; Jin SW
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):239-43. PubMed ID: 10452099
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of the biotinylated anti-HIV compound BMMP and the target identification study.
Kamo M; Tateishi H; Koga R; Okamoto Y; Otsuka M; Fujita M
Bioorg Med Chem Lett; 2016 Jan; 26(1):43-5. PubMed ID: 26615887
[TBL] [Abstract][Full Text] [Related]
40. 9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.
Guendel I; Carpio L; Easley R; Van Duyne R; Coley W; Agbottah E; Dowd C; Kashanchi F; Kehn-Hall K
Virol J; 2009 Jul; 6():114. PubMed ID: 19630958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
